European Journal of Molecular & Clinical Medicine

Abstract

Meningioma comprises majority of the intracranial tumors. They arise from the meningothelial cells (MECs) and are usually slow growing and benign in nature. Few meningiomas have a complicated histology and occur in compromising locations are very difficult to treat. Such cases have poor prognostic outcomes. This necessitates prompt diagnosis of the tumor and a proper understanding of its severity that can help in better management of the patients in future.